BMS-986165 IS A HIGHLY POTENT AND SELECTIVE ALLOSTERIC INHIBITOR OF TYK2, BLOCKS IL-12, IL-23 AND TYPE I INTERFERON SIGNALING AND PROVIDES FOR ROBUST EFFICACY IN PRECLINICAL MODELS OF INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Xie, Jenny H.
Gillooly, Kathleen
Zhang, Yifan
Yang, Xiaoxia
Zupa-Fernandez, Adriana
Cheng, Lihong
Strnad, Joann
Heimrich, Elizabeth
Zhou, Xiaodi
Chen, Jing
Chaudhry, Charu
Li, Sha
Moslin, Ryan
Wrobleski, Stephen
Burke, James
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
349
引用
收藏
页码：S1357 / S1357
页数：1
相关论文
共 3 条
  • [1] BMS-986165 Is a Highly Potent and Selective Allosteric Inhibitor of Tyk2, Blocks IL-12, IL-23 and Type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Systemic Lupus Erythematosus and Inflammatory Bowel Disease
    Gillooly, Kathleen
    Zhang, Yifan
    Yang, Xiaoxia
    Zupa-Fernandez, Adriana
    Cheng, Lihong
    Strnad, Joann
    Cunningham, Mark
    Heimrich, Elizabeth
    Zhou, Xiadi
    Chen, Jing
    Chaudhry, Charu
    Li, Sha
    McIntyre, Kim
    Carman, Julie
    Moslin, Ryan
    Wrobleski, Stephen
    Weinstein, David
    Burke, James
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] A selective TYK2 inhibitor, BMS-986165, decreases the transcriptional signature of Th17, IL-12, and interferon pathways in skin of psoriasis: results from a Phase 2 trial
    Catlett, I.
    Hu, S.
    Banerjee, S.
    Krueger, J. G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : B2 - B2
  • [3] Selective Inhibition of Tyrosine Kinase 2 (TYK2) with BMS-986165 Is Efficacious in IL-23-Mediated Diseases: Evidence from Preclinical IBD Models and From a Psoriasis Study
    Burke, James R.
    Cheng, Lihong
    Strnad, Joann
    Zhang, Yifan
    Heimrich, Elizabeth M.
    Gillooly, Kathleen M.
    Xie, Jenny
    Zupa-Fernandez, Adriana
    Papp, Kim
    Gordon, Kenneth
    Girgis, Ihab G.
    Kundu, Sudeep
    Banerjee, Subhashis
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S354 - S354
1